ARCHIVES

ORI Misconduct Findings Announced In Two Cases

This article is from The Cancer Letter archive.

Vol. 22 No. 28 | July 12, 1996

Download PDF Visit The Full Archive

Related Articles

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings

June 8, 1990

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

July 23, 1993

Austria Has highest Cancer Rate, Little NCI Support

June 17, 1977